Business
Evofem's PHEXXI Submitted for Marketing Approval in United Arab Emirates by Pharma 1 Drug Store
Women's health innovator Evofem Biosciences, Inc. (OTCPK: EVFM) announced today that private Emirati health care company Pharma 1 Drug Store LLC has filed an application with the United Arab Emirates (UAE) Ministry of Health and Prevention (MOHAP) seeking approval to commercialize PHEXXI® (lactic acid, citric acid, and potassium bitartrate) Evofem's FDA-approved hormone-free contraceptive, in the UAE.
About this update from Evofem Biosciences, Inc.
[{"type":"text","content":"— Pharma 1 Will Place Launch Quantity Order for PHEXXI in July 2025 — ","length":69,"tagName":"p","attribs":{}},{"type":"text","content":"— Commercial Launch in UAE Targeted for Q1 2026 —","length":49,"tagName":"p","attribs":{}},{"type":"text","content":"SAN DIEGO, June 23, 2025 /PRNewswire/ -- Women's health innovator Evofem Biosciences, Inc. (OTCPK: EVFM) announced today that private Emirati health care company Pharma 1 Drug Store LLC has filed an application with the United Arab Emirates (UAE) Ministry of Health and Prevention (MOHAP) seeking approval to commercialize PHEXXI® (lactic acid, citric acid, and potassium bitartrate) Evofem's FDA-approved hormone-free contraceptive, in the UAE.","length":473,"tagName":"p"},{"type":"image","alt":"Women's health innovator Evofem Biosciences (OTCQB: EVFM) (PRNewsfoto/Evofem Biosciences, Inc.)","displaySize":"","headline":null,"caption":"Women's health innovator Evofem Biosciences (OTCQB: EVFM) (PRNewsfoto/Evofem Biosciences, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":209,"url":"https://media.zenfs.com/en/prnewswire.com/b0b393f2cbffee7b6c52a7dea7c44bd2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/s3aOPVcdo91_a65mo20iIg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM2ODtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/b0b393f2cbffee7b6c52a7dea7c44bd2","width":400,"height":209}},"href":"https://mma.prnewswire.com/media/780907/Evofem_Biosciences_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""With the submission to MOHAP now complete, we are developing our commercial strategy for PHEXXI in the UAE and look forward to launching this important product as quickly as possible following approval," said Abdulwahab Atfah, CEO of Pharma 1 Drug Store. "Market research indicates a growing demand for hormone-free, on demand contraception in the UAE and the surrounding region. We expect PHEXXI will be extremely well received among OB/GYNs and the women they serve."","length":490,"tagName":"p"},{"type":"text","content":""This filing is an important milestone towards the commercialization of PHEXXI outside the U.S.," said Evofem CEO Saundra Pelletier. "We look forward to expanding and diversifying our revenue stream with PHEXXI sales to Pharma 1 for ...